FDA处理兽药残留问题 宾州一乳牛场同意停止不当用药

    食品伙伴网导读：美国宾夕法尼亚州的一家乳牛场已同意遵守联邦条例，避免由屠宰之前对乳牛进行未经批准的药物治疗而引起的牛肉上的非法药物残留。而这是对美国食品药品管理局颁布的永久性禁令的服罪判决书的一部分。这家乳业公司及其公司相关负责人7月26日因违反FDA的相关规定，由美国宾夕法尼亚州法院进行了审讯和判决。法官判决：该乳牛场在未满足数个要求之前，不得未经批准销售动物性食品，而这些要求包括：建立由FDA批准的数据保留系统，以追踪接受药物治疗的动物以及用药的剂量。判决中还写道，在该农场恢复销售动物性食品后，若FDA发现该农场违反本次判决，FDA有权要求其停止营业并交纳罚款。FDA正在关注作为人类食物的动物性食品的销售，因为可能含有对人体健康造成不良影响的非法兽药残留水平。美国食品药物管理局批准的新兽药使用要求，包括在动物在治疗和屠宰之间相间隔的时间，以确保食用部分中的兽药残留已经降低到对人类健康无损的水平。

原文报道： Owners agree to keep illegal drug residues out of animals sold for human consumption

A Pennsylvania dairy farm has agreed to abide by federal regulations that protect meat from illegal drug residues caused by the unapproved medication of cattle before slaughter, as part of a consent decree of permanent injunction obtained by the U.S. Food and Drug Administration.

The FDA action against H.B. Williams Inc., of Kingsley, Pa., and company owners Donna L. Williams, Jeffrey D. Williams, and Mark H. Williams, was taken July 26, 2010, in the U.S. District Court for the Middle District of Pennsylvania.

Under the decree signed by U.S. District Judge James M. Munley the farm is not permitted to sell animals for food unless and until it meets several requirements, including establishment of a recordkeeping system approved by the FDA to track the identity of medicated animals and the drugs and dosages given. After the farm resumes selling animals for food, the decree authorizes the FDA to require the farm to cease operations and pay fines if FDA determines that the farm has violated the decree.

The FDA is concerned about the sale of animals for human food that may contain illegal levels of animal drugs because of the potential for adverse effects on human health. The FDA approves new animal drugs with requirements, including a specified time period to withdraw an animal from treatment prior to slaughter, to ensure that a drug has been depleted from edible tissue to a level safe for humans.

The dairy farm sold animals through local livestock auctions to slaughterhouses that ship beef products to customers in New Jersey, New York, Maine, and Michigan.

The drug residues detected in tissue samples of the farm’s dairy cows and veal calves during tests by the U.S. Department of Agriculture's Food Safety Inspection Service included antibiotics such as neomycin, flunixin, desfuroylceftiofur, and sulfamethazine at levels not permitted by the FDA.